This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Menu
Follow UroToday
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mCRPC Treatment
Charles Ryan, MD
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Neal Shore, MD, FACS
A Patient Journey
Alicia Morgans, MD, MPH
Charles J. Ryan, MD
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Transformative Evidence
mCRPC
CARD Trial
PROfound Study
mHSPC
ENZAMET Trial
nmCRPC
PROSPER Trial
Advanced Prostate Cancer
HERO Trial
Bladder Cancer
Bladder Cancer Detection
Videos
Conference Coverage and Experts Group
Interviews with Experts at Conferences
ASCO GU 2021 Bladder and Kidney Cancer
ASCO GU 2021 Prostate Cancer
ASCO 2019
ASCO 2020
ASCO GU 2020
ESMO 2020
Exclusive Collaborations
APCCC 2019
LUGPA Annual Meeting 2019
PCF 2019
SNMMI Curriculum
UroToday Exclusives
A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
Book Club
Clinical Trials in Progress
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
COVID-19 and Genitourinary Cancers Videos
Journal Club
Large Urology Group Practice Association (LUGPA)
Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
Urologic Oncology
Prostate Cancer
Advances in Nuclear Medicine, PET, and Theranostics
Advanced Prostate Cancer
Cardiovascular Disease in Men with Prostate Cancer
CRPC with Bone Metastases
The Expert Voice
Imaging: Prostate Cancer
Localized Prostate Cancer
mCRPC
mHSPC
Molecular Diagnostics
Navigating Cancer
nmCRPC
The Patient Voice
Precision Medicine in Prostate Cancer
Prostate Cancer
Right Group
Bladder Cancer
Bladder Cancer
Bladder Cancer Expert Debates
Advanced Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Kidney Cancer
Advanced Kidney Cancer
Renal Cancer
Upper Tract Urothelial Tumors
Upper Tract Urothelial Carcinoma
Pelvic Health & Reconstruction
Bladder Health
Indwelling Catheters
Intermittent Catheters
Nocturia & Lower Urinary Tract Conditions
Endourology
Endourology Today
Endourology
Journals
Everyday Urology - Oncology Insights
From the Editor
Current Issue
Previous Issues
Prostate Cancer and Prostatic Diseases
From the Editor
Current Article
Previous Articles
Clinical Trials
Clinical Trials
Search Clinical Trials
From the Editor
Current Letter
Previous Letters
Conference Coverage
Advanced Prostate Cancer Consensus Conference (APCCC)
2019 APCCC Meeting
American Society of Clinical Oncology (ASCO)
2021 ASCO GU Symposium
2020 Virtual Education Program
2020 Annual Meeting
2020 ASCO GU Symposium
American Urological Association (AUA)
2020 Annual Meeting
ANZUP Mini Annual Scientific Meeting (ASM)
2020 Virtual Annual Meeting
Bladder Cancer Advocacy Network (BCAN)
2020 Think Tank Virtual Program
EAU Section of Oncological Urology
ESOU 2021
EMUC
2020 Annual Meeting
European Association of Urology (EAU)
2020 Annual Congress
European Society for Medical Oncology (ESMO)
2020 Virtual Congress
Global Society of Rare GU Tumors
2020 Meeting
International Bladder Cancer Network (IBCN)
2020 Annual Virtual Meeting
NMIBC - Drug Development 2021
2021 Annual Meeting
Prostate Cancer Academy
2020 Annual Meeting
Société Internationale d'Urologie (SIU)
2020 Annual Congress
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
2020 Congress
Society of Urologic Oncology (SUO)
2020 Annual Meeting
2020 SUO - AUA Summer Webcast
Targeted Alpha Therapy (TAT)
2019 Symposium
Articles
Urologic Oncology
Adrenal Diseases
Bladder Cancer
CRPC w/ Bone Metastases
Penile Cancer
Prostate Cancer
Renal Cancer
Testicular Cancer
Upper Tract Tumors
Investigative Urology
Men's Health
Androgen Deficiency
BPH
Erectile Dysfunction
Male Infertility
Peyronie’s Disease
Prostatitis
Vasectomy
Pelvic Health & Reconstruction
Fecal Incontinence
Fistula
GU Trauma & Reconstruction
Indwelling Catheters
Infections
Intermittent Catheters
Interstitial Cystitis
Neurogenic Bladder
Nocturia
Overactive Bladder
Pelvic Prolapse
Post-prostatectomy Incontinence
Stress Incontinence
Underactive Bladder
Urethral Strictures
Urinary Incontinence
Urinary Retention
Urinary Tract Infection – CAUTIs
Urologic Catheters
Endourology & Urolithiasis
Minimally Invasive Procedures
Stone Disease
Pediatric Urology
Pediatric Urology
COVID-19 and Genitourinary Cancers
COVID-19 and Genitourinary Cancers
Calendar
UroToday Home
Conference Highlights
ASCO GU 2021
ASCO GU 2021
Prostate Cancer
Bladder Cancer
Kidney Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
ASCO GU 2021 Kidney Cancer
Viewing 1-20 of 38 articles
ASCO GU 2021: The CLEAR Study of Lenvatinib Plus Pembrolizumab or Everolimus vs Sunitinib and the SWOG 1500 Trial of Sunitinib, Cabozantinib, Crizotinib, and Savolitinib in Advanced Kidney Cancer: Discussion
ASCO GU 2021: MK-6482 in Patients with Patients with Clear Cell Renal Cell Carcinoma: Discussion
ASCO GU 2021: The Oral HIF-2 α Inhibitor MK-6482 in Patients with Advanced Clear Cell Renal Cell Carcinoma (RCC): Updated Follow-up of a Phase I/II Study
ASCO GU 2021: Phase 3 Trial of Lenvatinib plus Pembrolizumab or Everolimus Versus Sunitinib Monotherapy as a First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (CLEAR Study)
ASCO GU 2021: Patterns of Progression in Patients Treated with Nivolumab plus Ipilimumab (NIVO+IPI) Versus Sunitinib (SUN) for First-Line Treatment of Advanced Renal Cell Carcinoma (aRCC) in CheckMate 214
ASCO GU 2021: Phase 2 Study of the Oral Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor MK-6482 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Radiology “Write This Down” - What Do Nonradiologists Need to Know
ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Quality of Life Corner
ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Cure the Cancer or Avoid Dialysis? Helping Decide
ASCO GU 2021: Bench to Bedside: Critical Pathways in Renal Cell Carcinoma – Peri-Operative Morbidity and Mortality in a Modern Series of Patients Treated with Cytoreductive Nephrectomy at Five Centers
ASCO GU 2021: Best of the Journals: Renal Cell Carcinoma – Surgery
ASCO GU 2021: Best of the Journals: Renal Cell Carcinoma – Pathology
ASCO GU 2021: Best of Journals: Renal Cell Carcinoma – Medical Oncology
ASCO GU 2021: Outcomes of First-Line Immuno-Oncology Combination Therapies in Metastatic Renal Cell Carcinoma: Results from the International mRCC Database Consortium
ASCO GU 2021: Stereotactic Radiotherapy and Pembrolizumab for Oligometastatic Renal Tumors: The RAPPORT Trial
ASCO GU 2021: Angiogenic and T-Effector Subgroups Identified by Gene Expression Profiling and Propensity for PBRM1 and BAP1 Alterations in Clear Cell Renal Cell Carcinoma
ASCO GU 2021: TIVO-3: Tivozanib in Patients with Advanced Renal Cell Carcinoma Who Have Progressed After Treatment with Axitinib
ASCO GU 2021: NAXIVA: A Phase II Neoadjuvant Study of Axitinib for Reducing Extent of Venous Tumor Thrombus in Clear Cell Renal Cell Cancer with Venous Invasion
ASCO GU 2021: Sarcomatoid Versus Clear Cell RCC: A Comparative Comprehensive Genomic Profiling Study
ASCO GU 2021: Illustration of Temporal Evolution in Patients with mRCC Using Both ctDNA and Tissue-Based Genomic Data
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free